OBJECTIVE: While published risk assessment tools for postpartum hemorrhage (PPH) have been widely used, these risk assessment tools were created based on expert opinion. Data regarding the validity of these risk assessment tools are limited, particularly in women undergoing cesarean delivery. We sought to examine the validity of three known risk assessment tools ( We conducted a retrospective cohort study evaluating all women undergoing cesarean delivery at 23 weeks' gestation between 2012 and 2017 at an urban hospital with an average of 1,200 cesarean deliveries per year. Women with missing information were excluded. Severe PPH was defined as estimated blood loss 1000 mL requiring transfusion of packed red blood cells. Women were stratified into low-risk, medium-risk, and high-risk groups using risk assessment tools. Odds ratios (OR) with 95% confidence interval (95%CI) were calculated according to risk stratification. Risk factors were examined using multivariable logistic regression according to risk assessment tools. Receiver operating characteristic curves with the area under a curve (AUC) and 95%CI were created according to each risk assessment tool.
OBJECTIVE: While published risk assessment tools for postpartum hemorrhage (PPH) have been widely used, these risk assessment tools were created based on expert opinion. Data regarding the validity of these risk assessment tools are limited, particularly in women undergoing cesarean delivery. We sought to examine the validity of three known risk assessment tools (California Maternal Quality Care Collaborative [CMQCC] , Association of Women's Health, Obstetric and Neonatal Nurses [AWHONN] , and New York Safety Bundle for Obstetric Hemorrhage [NYSBOH] in women undergoing cesarean delivery. STUDY DESIGN: We conducted a retrospective cohort study evaluating all women undergoing cesarean delivery at 23 weeks' gestation between 2012 and 2017 at an urban hospital with an average of 1,200 cesarean deliveries per year. Women with missing information were excluded. Severe PPH was defined as estimated blood loss 1000 mL requiring transfusion of packed red blood cells. Women were stratified into low-risk, medium-risk, and high-risk groups using risk assessment tools. Odds ratios (OR) with 95% confidence interval (95%CI) were calculated according to risk stratification. Risk factors were examined using multivariable logistic regression according to risk assessment tools. Receiver operating characteristic curves with the area under a curve (AUC) and 95%CI were created according to each risk assessment tool.
RESULTS:
Of 6,925 women who underwent cesarean delivery, 293 (4.2%) had severe PPH. All risk assessment tools correctly classified high-risk women as having higher odds of severe PPH compared to women who were classified as low risk (see Table 1 ). The analyzed risk factors included in risk assessment tools were significantly associated with increased odds of severe PPH (p<.05) except for macrosomia (all tools), prolonged second stage (AWHONN and NYSBOH), induction or augmentation of labor (AWHONN), and body mass index (all tools) (see Table 2 ). However, all risk assessment tools had low AUCs Tel Aviv University, Israel, Israel OBJECTIVE: To describe the patterns of physiological and emotional stress during labor as measured by salivary cortisol levels and their correlation to obstetric and neonatal outcomes. STUDY DESIGN: A prospective, observational study that included a cohort of 167 women with low-risk singleton term deliveries at a tertiary academic center. Physiological stress was evaluated by salivary cortisol measurements and emotional stress by questionnaires during different stages of labor: latent phase, active phase, full dilation, 2 minutes, 2 hours and 24 hours after delivery. Cord blood cortisol and pH were also obtained. Modes of delivery, complications during labor and delivery, and early neonatal outcomes were also evaluated. RESULTS: Salivary cortisol levels increased gradually from latent phase to active phase (Fig. 1) . The maximum increase was observed within two minutes of the delivery (from an average of 1.06 mcg/dl to 1.67 mcg/dl: 57% increase). Within two hours from the delivery, cortisol decreased and reached a non-gravid level after 24 hours (0.16 mcg/dl). Cortisol levels during labor and up to 2 hours postpartum were above the average level of non-gravid women (0.5 mcg/dl). Nulliparous had significantly higher cortisol levels compared to multiparas when measured 2 minutes (p¼0.03) and 2 hours postpartum (p¼0.041), with no difference 24 hours after the delivery (p¼0.666) (Fig. 2) . Women with epidural had lower cortisol levels at a complete dilation (p¼0.026) and 2 hours postpartum (p¼0.016) compared to women without epidural. Cortisol levels 24 hours postpartum were similar in patients delivered with or without epidural analgesia (p¼0.917). No difference was found in cortisol levels between women who had normal vaginal delivery (NVD) compared to cesarean delivery (CD), except for higher cortisol levels 2 hours after CD (mean 2 vs. 0.85, p¼0.035). Emotional stress peaks during latent and full dilation phases (mean 4.56, 4.29, respectively). Maximum decrease from 4.29 to 2.04 (52%) occurs immediately postpartum. There is a positive correlation between cord cortisol after vacuum extraction (p¼0.04) and no correlation between CD and NVD (p¼0.231). CONCLUSION: This study establishes a cortisol labor curve for low-risk pregnancies. Salivary cortisol may be used for further planning of ways to decrease stress during labor.
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Northwestern University Feinberg School of Medicine, Chicago, IL OBJECTIVE: Regional analgesia is widely used and a highly effective modality for intrapartum pain management. However, the association of intrapartum regional analgesia with subsequent opioid use has not been described. We sought to evaluate whether use of intrapartum regional analgesia is associated with postpartum opioid utilization after vaginal delivery. STUDY DESIGN: Retrospective cohort study of all women who underwent vaginal delivery at a tertiary care center (12/2015-16) . Women were excluded if they had an allergy to NSAIDs or morphine. Inpatient records were queried for delivery details, patient demographic and clinical characteristics, and provider characteristics. Medication administration records were queried for time-tofirst opioid dose following delivery and opioid use during the postpartum hospitalization. Postpartum opioid use was converted to morphine milligram equivalents (MME) and analyzed as MME per day to standardize dosing over variable lengths of stay. Bivariable and multivariable Cox and linear regression models were used to examine the associations of regional analgesia with 1) time-to-first postpartum opioid dose and 2) daily inpatient postpartum opioid use. RESULTS: Of 9,038 eligible women who underwent vaginal delivery, 86.8% used intrapartum regional analgesia. Women who used regional analgesia had a longer mean time-to-first postpartum opioid dose (9.45 vs. 3.78 hours, p<0.001) (Figure) . Of women who used an opioid in the postpartum period, the median MME per day for those who used regional analgesia was 15.83 ), compared to 13.78 MME per day for those who did not use regional analgesia (p¼0.113) (Table) . On multivariable Cox regression adjusting for potential confounders, use of regional analgesia was associated with a nearly 40% longer time-to-first opioid dose (aHR 0.63, 95% CI 0.55-0.72). Regional analgesia was not significantly associated with amount of daily opioid use (b -0.50, 95% CI -2.89 to 1.89). CONCLUSION: Following vaginal delivery, use of intrapartum regional analgesia is associated with a significant prolongation in time-to-first opioid dose but is not associated with a change in daily opioid use.
